Bulletin 204: Trimipramine
Trimipramine is a tricyclic antidepressant (TCA) that has been subject to significant price increases. Consequently, it does not represent a cost-effective choice of treatment. This bulletin reviews the use of trimipramine with resources to support stopping or switching treatment in depression in adults. Audit tools including a template patient information/switch guide are provided to support implementation of change.